已收录 268921 条政策
 政策提纲
  • 暂无提纲
Proadrenomedullin N‐terminal 20 peptide (PAMP) elevates blood glucose levels via bombesin receptor in mice
[摘要]

We found a potent hyperglycemic effect of proadrenomedullin N-terminal 20 peptide (PAMP) after intra-third cerebroventricular administration at a dose of 10 nmol in fasted mice. PAMP has four homologous residues with bombesin (BN), a hyperglycemic peptide. PAMP showed affinity for gastrin-releasing peptide preferring receptor (GRP-R) and neuromedin B preferring receptor. The PAMP-induced hyperglycemic effect was inhibited by [D-Phe6, Leu-NHEt13, des-Met14]-BN (6–14), GRP-R specific antagonist, indicating that the hyperglycemic effect is mediated at least in part via GRP-R. Furthermore, pretreatment of α-adrenergic blocker inhibited the PAMP-induced hyperglycemia and hyperglucagonemia, suggesting that the increase of glucagon secretion through α-adrenergic activation is involved in this hyperglycemic effect of PAMP.

[发布日期]  [发布机构] 
[效力级别]  [学科分类] 生物化学/生物物理
[关键词] Proadrenomedullin N-terminal 20 peptide;Hyperglycemia;Bombesin;Gastrin-releasing peptide preferring receptor;α-Adrenergic activation;PAMP;proadrenomedullin N-terminal 20 peptide;BN;bombesin;GRP-R;gastrin-releasing peptide preferring receptor;i.c.v.;intra-third cerebroventricular [时效性] 
   浏览次数:19      统一登录查看全文      激活码登录查看全文